abstract |
(HETERO)ARIL CYCLE-PROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS. The invention relates to (hetero)aryl cyclopropylamine compounds, particularly including the compounds of formula I as described and defined herein, and their use in therapy, including, for example, in the treatment or prevention of cancer, a disease or neurological condition, or a viral infection. |